Spermidine
Sponsors
Medical University of Graz, University of California, Davis, Chrysea Labs Lda, University of Aarhus, West China Hospital
Conditions
AgingCardiovascular DiseasesCognition DisorderCognitive ImpairmentDiabetes Mellitus, Type 2Diastolic DysfunctionDietary HabitsFormer Smokers
Phase 1
A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)
RecruitingNCT07035626
Start: 2025-06-25End: 2026-06-08Target: 58Updated: 2025-06-26
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
RecruitingNCT07058974
Start: 2025-08-25End: 2026-07-01Target: 22Updated: 2025-09-25
Phase 2
Phase 3
Unknown Phase
Absorption and Digestion Kinetics of Human Metabolites
CompletedNCT05017428
Start: 2021-04-08End: 2021-07-01Updated: 2021-08-23
Bioavailability of Spermidine in Healthy Males
Active, not recruitingNCT06017219
Start: 2023-05-05End: 2024-12-14Target: 6Updated: 2024-08-30
Iterative Design Trial to Assess Dietary Supplements and Other Aging-targeted Therapies
Enrolling by invitationNCT07202403
Start: 2025-09-30End: 2031-09-30Target: 10Updated: 2025-10-01